MAPT and Alzheimer disease: Notably, evidence for aberrant expression of coding and non-coding genes, including repeat elements, has been reported in patients and in tau animal models of AD [28, 29, 65] that also display reduced H3K9me3 [26] or H3K9me2 staining signals [28, 29].